Literature DB >> 17706838

Synthesis, properties and photodynamic inactivation of Escherichia coli by novel cationic fullerene C60 derivatives.

Mariana B Spesia1, M Elisa Milanesio, Edgardo N Durantini.   

Abstract

A novel N,N-dimethyl-2-(4'-N,N,N-trimethylaminophenyl)fulleropyrrolidinium iodide (DTC(60)(2+)) has been synthesized by 1,3-dipolar cycloaddition using 4-(N,N-dimethylamino) benzaldehyde, N-methylglycine and fullerene C(60). This approach produced an N-methyl-2-(4'-N,N-dimethylaminophenyl)fulleropyrrolidine with 38% yield. Exhaustive methylation of this fullerene derivative with methyl iodide yielded 95% of dicationic DTC(60)(2+). The spectroscopic and photodynamic properties of the DTC(60)(2+) were compared with a non-charged N-methyl-2-(4'-acetamidophenyl)fulleropyrrolidine (MAC(60)) and a monocationic N,N-dimethyl-2-(4'-acetamidophenyl)fulleropyrrolidinium iodide (DAC(60)(+)). The dicationic DTC(60)(2+) is essentially aggregated in solution of different solvents and it is partially dissolved as monomer in benzene/benzyl-n-hexadecyldimethyl ammonium chloride (BHDC) 0.1M/water (W(0)=10) reverse micelles. The singlet molecular oxygen, O(2) ((1)Delta(g)), production was evaluated using 1,3-diphenylisobenzofuran. The photodynamic effect was strongly dependent on the medium, diminishes when the sensitizer is aggregated and increases in an appropriately surrounded microenvironment. The photodynamic inactivation produced by these fullerene derivatives was investigated in vitro on a typical Gram-negative bacterium, Escherichia coli. Photosensitized inactivation of E. coli cellular suspensions by DTC(60)(2+) exhibits a approximately 3.5 log decrease of cell survival (99.97% of cellular inactivation), when the cultures are treated with 1 microM of sensitizer and irradiated for 30 min. This photosensitized inactivation remains high even after one washing step. Also, the photodynamic activity was confirmed by growth delay of E. coli cultures. The growth was arrested when E. coli was exposed to 2 microM of cationic fullerene and irradiated, whereas a negligible effect was found for the non-charged MAC(60). These studies indicate that dicationic DTC(60)(2+) is an interesting agent with potential applications in photodynamic inactivation of bacteria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17706838     DOI: 10.1016/j.ejmech.2007.06.014

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  14 in total

1.  Photodynamic therapy with fullerenes in vivo: reality or a dream?

Authors:  Sulbha K Sharma; Long Y Chiang; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2011-12       Impact factor: 5.307

2.  Can nanotechnology potentiate photodynamic therapy?

Authors:  Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2012-03       Impact factor: 7.848

3.  A novel tricationic fullerene C60 as broad-spectrum antimicrobial photosensitizer: mechanisms of action and potentiation with potassium iodide.

Authors:  Maximiliano L Agazzi; Javier E Durantini; Ezequiel D Quiroga; M Gabriela Alvarez; Edgardo N Durantini
Journal:  Photochem Photobiol Sci       Date:  2021-03-04       Impact factor: 3.982

Review 4.  Photosensitizers in antibacterial photodynamic therapy: an overview.

Authors:  Jaber Ghorbani; Dariush Rahban; Shahin Aghamiri; Alireza Teymouri; Abbas Bahador
Journal:  Laser Ther       Date:  2018-12-31

Review 5.  Drug discovery of antimicrobial photosensitizers using animal models.

Authors:  Sulbha K Sharma; Tianhong Dai; Gitika B Kharkwal; Ying-Ying Huang; Liyi Huang; Vida J Bil De Arce; George P Tegos; Michael R Hamblin
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 6.  Functionalized fullerenes in photodynamic therapy.

Authors:  Ying-Ying Huang; Sulbha K Sharma; Rui Yin; Tanupriya Agrawal; Long Y Chiang; Michael R Hamblin
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

Review 7.  Photodynamic therapy with fullerenes.

Authors:  Pawel Mroz; George P Tegos; Hariprasad Gali; Tim Wharton; Tadeusz Sarna; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2007-10-08       Impact factor: 3.982

8.  Fullerenes as photosensitizers in photodynamic therapy: pros and cons.

Authors:  Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2018-07-25       Impact factor: 3.982

9.  Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials.

Authors:  Liyi Huang; Mitsuhiro Terakawa; Timur Zhiyentayev; Ying-Ying Huang; Yohei Sawayama; Ashlee Jahnke; George P Tegos; Tim Wharton; Michael R Hamblin
Journal:  Nanomedicine       Date:  2009-11-12       Impact factor: 5.307

Review 10.  Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs.

Authors:  Rui Yin; Tanupriya Agrawal; Usman Khan; Gaurav K Gupta; Vikrant Rai; Ying-Ying Huang; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.